THQM — Tchaikapharma High Quality Medicines AD Balance Sheet
0.000.00%
Last trade - 00:00
- BGN1.46bn
- BGN1.47bn
- BGN48.55m
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.041 | 0.046 | 0.057 | 0.142 | 0.073 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 74 | 60 | 57.5 | 58.8 | 60.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 82.8 | 71 | 70.7 | 75.7 | 80.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 27 | 37.1 | 38.1 | 35.3 | 33.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 118 | 117 | 117 | 120 | 122 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 17.8 | 17.1 | 15.7 | 15.6 | 15.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 21.3 | 20.2 | 18.6 | 18.3 | 17.5 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 96.5 | 97.1 | 98.8 | 102 | 105 |
Total Liabilities & Shareholders' Equity | 118 | 117 | 117 | 120 | 122 |
Total Common Shares Outstanding |